OTHER VOICES

Modern Healthcare - - OPINIONS EDITORIALS -

“The U.S. Pre­ven­tive Ser­vices Task Force bucked the (con­ven­tional) think­ing when it re­leased its final rec­om­men­da­tions re­gard­ing screen­ings for prostate can­cer. Af­ter re­view­ing the sci­en­tific ev­i­dence, the 16-mem­ber panel of health­care ex­perts rec­om­mended that the prostate­spe­cific anti­gen test no longer should be of­fered rou­tinely to men at any age. It con­cluded that the ef­fec­tive­ness of the PSA blood test, which screens for pro­tein that may in­di­cate prostate can­cer, is overblown and that the test does more harm than the ben­e­fits are worth.” —Akron Bea­con Jour­nal (Ohio) “The U.S. Pre­ven­tive Ser­vices Task Force has an­nounced its final rec­om­men­da­tion on Psa-based prostate can­cer screen­ing. It finds that the known harms of screen­ing out­weigh the po­ten­tial ben­e­fits for men who have no can­cer symp­toms. … While I hope that this new rec­om­men­da­tion will put an end to mass screen­ing, I am not op­ti­mistic. As Up­ton Sin­clair once said, ‘It is dif­fi­cult to get a man to un­der­stand some­thing, when his salary de­pends on his not un­der­stand­ing it.’ ” —Dr. Otis Braw­ley, Amer­i­can Can­cer So­ci­ety chief med­i­cal of­fi­cer, on CNN.COM

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.